LLY Healthcare
Eli Lilly & Co.
| P/E Trailing | -- |
| P/E Forward | -- |
| PEG Ratio | -- |
| Market Cap | -- |
| Price Target | -- |
| D/E Ratio | -- |
| Current Ratio | -- |
| Cash | -- |
| Total Debt | -- |
| Net Cash | -- |
| Gross Margin | -- |
| Operating Margin | -- |
| Net Margin | -- |
| ROE | -- |
| FCF | -- |
| GF Score | -- |
| Altman Z-Score | -- |
| Piotroski F-Score | -- |
| Div. Yield | -- |
| Analyst Rating | -- |
STRONG SELL: Metrics within normal ranges.
Stocks rebounded as President Donald Trump said he won't go ahead with Greenland tariffs, citing a "framework" for a future deal. Google and Eli Lilly lead new buys.
Eli Lilly is Wednesday's IBD Stock Of The Day. Lilly shares are bounding off their 50-day line with a new buying opportunity in sight.
Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +1.05% and +1.84%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for …
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.5% in the afternoon session after the U.S. Food and Drug Administration (FDA) granted a Breakthrough Therapy designation for its drug, …
Eli Lilly wins FDA Breakthrough Therapy status for sofetabart mipitecan in certain patients with platinum-resistant ovarian cancer.
If you are wondering whether Eli Lilly's current share price reflects its true worth, you are not alone. This article is built to help you frame that question clearly. The …
TEM hits $1.1B TCV, signs 70+ pharma data deals and posts its first positive adjusted EBITDA in Q3 2025 as adoption accelerates.
Amgen Inc. (NASDAQ:AMGN) is one of the best undervalued wide moat stocks. On January 13, 2026, an announcement came regarding the Ro and Amgen Inc. (NASDAQ:AMGN) collaboration. Ro, a U.S. …
AbbVie Inc. (NYSE:ABBV) is one of the 10 Goldman Sachs undervalued stocks to invest in. On January 14, 2026, Reuters reported that AbbVie Inc. (NYSE:ABBV) is looking to deepen its …
Despite a challenging year, the company has a lot to look forward to in the coming years.